Introduction
According to the World Health Organization, cardiovascular disease and stroke are the foremost contributors to worldwide mortality with ischaemic heart disease globally causing almost nine million deaths per year in 2015. 1 Accurate mortality statistics are important for both policy-and decision-making regarding healthcare funding. For reliable statistics, it is essential to perform autopsies in a sufficient proportion of deaths, both in and out of hospital. Despite available modern diagnostic tests, the conventional autopsy still reveals unexpected findings related to the cause of death in 8.4-24.4% and findings that would have affected patient outcome (Class I errors) in 4.1-6.7% of cases. [2] [3] [4] Unfortunately, today's autopsy rate has dropped to alarmingly low percentages worldwide (0-15%), both for academic and non-academic hospitals. 5 In the late 90s, the imaging autopsy was introduced as an alternative to conventional autopsy as a stimulus to postmortem diagnostics. Since then, a growing number of studies have evaluated the diagnostic value of postmortem computed tomography (CT) and magnetic resonance imaging (MRI) with or without imageguided biopsies. Two review articles concluded that the imaging autopsy, using a non-invasive or minimally invasive approach, can potentially serve as an alternative to conventional autopsy, but more extensive research in different settings is needed to validate these new autopsy methods. 6, 7 Imaging protocols designed for the living patient differ from postmortem imaging protocols, in particular for cardiac imaging. For example, wall movement abnormalities of the heart cannot be diagnosed. In living patients, contrast-enhanced imaging, either noninvasive or invasive, is the gold standard for diagnosing ischaemic heart disease. Postmortem angiographic studies are feasible and not new; since the discovery of X-rays, angiography of organs and tissues has been used as an adjunct to the autopsy procedure. 8 More recently, postmortem total-body angiography, using CT or MRI, has become technically feasible, and there are a growing number of studies investigating its diagnostic value. Preliminary results are promising, especially for establishing ischaemic heart disease as the cause of death. [9] [10] [11] Interestingly postmortem MRI without the use of contrast agents also shows a sufficient accuracy for detecting both acute and chronic myocardial infarction (MI). The presence and age of MI can be diagnosed by evaluating the signal changes related to morphological alterations in the infarcted myocardium, such as the presence of myocardial oedema, fibrosis, or fat. [12] [13] [14] [15] Non-enhanced cardiac CT is also useful for detecting coronary artery calcifications. In this study, we evaluate the minimally invasive autopsy (MIA) approach using both non-enhanced CT and MRI followed by CT-guided biopsies. The aim of this study was to determine the diagnostic accuracy of MRI, CT, and CT-guided biopsy for the detection of acute and chronic MI, with conventional autopsy as the reference standard.
Methods

Study design
This study was undertaken as part of the MIA study; this is a prospective single centre cross-sectional study in a tertiary referral hospital comparing diagnostic performance of conventional autopsy and MIA. Conventional autopsy followed MIA on the same case. Pathologists involved with conventional autopsy were blinded to MIA findings as much as possible; however, biopsy sites could potentially lead to increased suspicion of the biopsied organs and tissues by the autopsy pathologist. MIA personnel were blinded to autopsy findings.
Patients
From January 2012 to December 2014 all hospitalized patients aged 18 years and older who died at Erasmus University Medical Center were eligible, if written informed consent was obtained from next-of-kin for MIA and conventional autopsy of at least the torso.
Exclusion criteria were (suspected) unnatural cause of death, body size exceeding height of 16 inches in supine position (limitation for MRI), known or suspected 'high-risk' infected bodies (tuberculosis, hepatitis B and C, human immunodeficiency virus, methicillin-resistant Staphylococcus aureus, and multi-drug resistant Acinetobacter), and open abdominal wounds that could not be completely closed or taped to prevent leakage of body fluids.
Clinical information
All relevant clinical information including medical history and suspected cause of death was recorded and available for both the MIA and the conventional autopsy team. The treating physician decided the most likely cause of death and a differential diagnosis based on the clinical presentation. For the analysis, the population was divided into a group with and a group without clinical suspicion for ischaemic heart disease.
MIA procedure
MRI and CT scans were made according to standardized protocols (Tables 1 and 2, respectively). Total acquisition time was 1 h for MRI and around 5 min for CT. One radiologist (A.C.W.) with expertise in postmortem radiology, performed the initial read of the MRI and CT scans, compared these to the available premortem imaging, and marked suspected pathological lesions on CT and MRI key images that were used to plan the biopsies.
MRI was performed on a 1.5T scanner (Discovery MR450, GE Medical systems, Milwaukee, WI, USA) and consisted of scans of the brain, neck, thorax, abdomen, and pelvis. The MRI total-body protocol consisted of axially-acquired short tau inversion recovery (STIR) fast spin echo (FSE) T2w and fluid attenuated inversion recovery (FLAIR) FSE T1w from the cranium to the pelvis. An additional 2D STIR FSE T2w scan and 3D Fatsat FSPGR T1w scan with higher resolution than the total-body scans were acquired of the thorax, using an 8-channel torso array coil. All MRI scans were made in the axial orientation.
After MRI was completed CT scans were acquired from head to feet (Somatom Definition, Siemens Healthcare, Forchheim, Germany). CT datasets of the head, thorax, and abdomen were reconstructed with section thickness of 1.0 mm and 5.0 mm in the axial plane and 3.0 mm in the coronal and sagittal planes, by using medium-to-smooth (H31/B31) and very sharp (H70/B70) convolution kernels.
CT-guided biopsies (12 Gauge) were taken from heart, lungs, liver, kidneys, spleen, and radiologically suspected pathology as indicated. In the heart, standard biopsies (5-10 samples) were taken from the lateral wall (mid-and basal-parts) and an apex of the left ventricle. Additional biopsies were taken from MRI signal abnormalities within the myocardium. In those cases where there was a clinical suspicion of MI and the MRI showed no signal abnormalities additional biopsies were taken from the septum, anterior, and posterior wall when in doubt, they consulted pathologists with specific expertise, not involved in the matching conventional autopsy, to reach a conclusion.
Cardiac imaging evaluation CT
For each case, CT calcium score was calculated by one observer (I.M.W.) using dedicated software (Syngo.via 3.0 Calcium Scoring V R , Siemens Healthcare, Forchheim, Germany) and expressed as total Agatston scores.
MRI
MR images were reconstructed and evaluated in the short-axis view. Two radiologists with expertise in cardiac radiology (A.C.W. and A.P.P.) independently evaluated MR images and in case of disagreement, consensus was reached in joint sessions. MIs were classified according to a modified classification by Jackowski et al. 12, 16, 17 Peracute infarction (within 6 h after onset) is characterized by T2 hypointense signal in the necrotic centre, caused by a state of hypoperfusion. In the acute phase (within 6 h-1 week after onset), the marginal areas become oedematous and show T2 hyperintense signal, T1 signal in the centre is isointense, and the oedematous marginal regions can show T1 hypointense signal. Subacute infarction (>1 week after onset) shows T2 hyperintense signal in the infarcted area when the area becomes reperfused, while the marginal areas show normal T1 and T2 signal. Chronic infarction (>2 months after onset) shows wall thinning and scar tissue reflected by T1 and T2 hypointense signal and foci of T1 hyperintense signal can be seen due to fatty infiltration.
In our analysis, peracute and acute infarctions were grouped into one category and defined as acute MI (<1-week old infarction). Subacute and chronic infarctions were grouped into one category and defined as chronic MI (>1-week old infarction). MRI criteria for determining infarction age are detailed in Table 3 .
Conventional autopsy
The day after MIA, a resident in pathology, supervised by the attending pathologist, performed conventional autopsy according to the departmental protocol. The autopsy report included medical history, postmortem diagnoses, a presumed cause of death, and answers to specific clinical questions, and was authorized by the pathologist. Macroscopic evaluation consisted of sectioning of the heart in slices of 0.5 to 1 cm and visual inspection of the myocardium. Lactate dehydrogenase (LDH) staining was performed on a mid-ventricular slice. Haematoxylin and eosin were used for histological staining. 18 When there was a discrepancy between the histology of the MIA and conventional autopsy, a pathologist with expertise in cardiac pathology (JHT) reviewed the histology. The following criteria for MI age were used (separately or in combination):
. acute MI: hypereosinophilia and loss of cross striation within myocardial fibres, contraction band necrosis, coagulation necrosis with or without granulocyte infiltration or haemorrhage, and various degrees of nuclear pyknosis, karyolysis, granulocyte infiltration, and myocardial oedema; chronic MI: fibroblasts with loose connective tissue formation, angiogenesis (subacute), and paucicellular collagenous fibrosis (chronic). 12 
Statistical analysis
Analyses were performed on the patient level. Conventional autopsy was used as the reference standard. We calculated sensitivity and specificity and 95% confidence intervals (CIs) for the detection of acute and chronic MI for MRI and for MIA (MRI, CT, and biopsies). CIs for sensitivity and specificity are Clopper-Pearson CIs. 19 Inter-observer agreement was calculated using kappa statistics. Calculations were performed using IBM
Receiver operating characteristics (ROC) curves
We calculated ROC curves to investigate diagnostic value of CT (total Agatston calcium score), MRI, and biopsies for diagnosing acute and chronic MI. In the analysis, the diagnostic value (sensitivity and specificity and ROC curves) of biopsies was combined with MRI, because biopsies were taken from radiologically suspect areas, identified at MRI.
Results
Case recruitment
From January 2012 to December 2014, 100 consecutive cases (62 men and 38 women) were included in the study. One case was excluded because autopsy findings warranted a forensic autopsy. The mean interval between death and start of imaging was 23.2 ± 15.6 h (range 3.2-71.6). Mean age at the time of death was 62.5 years (range 25-92). In the group with clinical suspicion of ischaemic heart disease, 14/30 (46%) patients were admitted to the hospital with out-of-hospital cardiac arrest vs. 3/69 (4%) in the group without clinical suspicion of cardiac death.
Agreement between clinical suspicion and autopsy findings
In the group with a clinical suspicion of ischaemic heart disease as the cause of death, acute MI was found in 16/30 (53.3%) of cases by conventional autopsy. In the group without clinical suspicion of ischaemic heart disease as the cause of death, acute MI was found in 18/69 (26.1%) cases. Twenty-two of the 34 cases with acute MI found with conventional autopsy had no known ischaemic heart disease during life.
Twenty cases had clinically known ischaemic heart disease during life (at least one ischaemic episode during life, determined by clinicians). MI, either chronic or acute, was confirmed by conventional autopsy and MIA in 16/20 of these cases (the same cases were identified with MIA and conventional autopsy).
Diagnostic performance
Acute MI was found in 34/99 cases on conventional autopsy and 36/ 99 cases on MIA. Chronic MI was found in 40/99 cases on conventional autopsy and 51/99 cases on MIA. The diagnostic accuracy of MRI and biopsies for the detection of acute and chronic MI is shown in Table 4 and for CT (Total Agatston calcium score) in Table 5 , and the ROC curves for acute and chronic MI are shown in Figures 1 and  2 , respectively.
Acute MI Sensitivity of MRI for acute MI was 0.50 (95% CI 0.32-0.68) and specificity was 0.92 (0.83-0.97). Sensitivity of MIA for acute MI was 0.97 (95% CI 0.85-1.00) and specificity was 0.95 (0.87-0.99). Figure 3 shows a case with acute MI.
The area under curve (AUC) for the detection of acute MI was 0.60 (95% CI 0.48-0.72) for CT (total Agatston calcium score), 0.71 (95% CI 0.60-0.83) for MRI, and 0.96 (95% CI 0.92-1.00) for MRI with biopsy (MIA). Five cases were classified as peracute infarction on MRI, in two of these cases, no evidence for an infarction was found on conventional autopsy. 
Discussion
In this study, we investigated the diagnostic accuracy of an MIA consisting of MRI, CT, and CT-guided biopsy for detection of ischaemic heart disease in a hospital setting. We found that the combination of MRI and biopsies had the highest accuracy for detecting acute and chronic MI with conventional autopsy as reference standard. MRI without biopsies showed a high specificity, but low sensitivity for acute and chronic MI. High CT Agatston calcium score (>400) was a good predictor for chronic MI, but not for acute MI. We found a lower sensitivity of MRI as a stand-alone test for acute MI (0.50) compared with other studies investigating MRI. Ruder et al. 20 reported that with MRI acute MI (within 3 h after onset) could be detected in ex vivo porcine hearts in which they correctly detected acute infarctions in all 21 cases. Forensic studies showed that with MRI acute and chronic MI (up to 100% sensitivity) could be accurately diagnosed in human subjects. Importantly, MRI could diagnose peracute MI (onset within 3 h) in cases not yet showing histological changes, but with a matching coronary stenosis at conventional autopsy. 12, 13, 17 The differences in sensitivity and specificity among studies can be explained by the differences in studied population and clinical setting; most are forensic studies that investigated subjects who died under the suspicion of an out-of-hospital cardiac-arrest and as such had a high pre-test probability. Also, these studies often involve highresolution cardiac imaging at 3T scanners using surface coils and relatively long scan time for imaging only the heart ($1 h). 16 Conversely, we scanned in a hospital setting and performed total-body imaging to diagnose both cardiac and non-cardiac cause of death. So as not to interfere with the patient workflow at the MR scanner, we were restricted to 1-h scan time for imaging the entire body. The addition of biopsies to MRI increased the sensitivity substantially. This highlights the importance of extensive sampling, even when no changes are visible yet on MRI. The big difference between sensitivity of MRI and MRI combined with biopsies can be explained by the quantity of sampling. From each biopsy location, at least five samples were taken, e.g. from the lateral wall, also the mid-and posterior-segments were biopsied. Furthermore, in those cases where there was a clinical suspicion of myocardial ischaemia and the MRI showed no signal abnormalities, extra biopsies were taken from the septum, anterior, and posterior wall (both mid-and posteriorsegments).
The non-invasive approach (CT and/or MRI) is less expensive than the minimally invasive approach (imaging plus biopsy). CT is now widely used as a stand-alone modality because of its high accessibility, short examination time, and robust performance. CT can provide better mortality statistics than the cause of death determined by the clinician, and is useful for excluding certain diagnoses. However, for diagnosing acute MI, our results show that the diagnostic accuracy of CT as stand-alone test is insufficient. 21, 22 To improve CT performance, in particular for ischaemic heart disease, more recent studies report on the diagnostic value of CT angiography. Grabherr et al. extensively performed feasibility studies on CTA using different contrast agents and perfusion techniques. There are different CTA approaches; it can be targeted at the coronary arteries by selective placement of the catheter at the level of the coronary ostia, or total-body CTA can be performed including multiphase scanning. 9, [23] [24] [25] Wichman et al. applied total-body CTA in 50 ICU patients who died unexpectedly or within 48 h of an event requiring resuscitation and found that CTA confirmed 93% of the clinical diagnoses, and autopsy confirmed 80%. In addition, CTA and CA identified 16 new major and 238 new minor diagnoses. They concluded that in cases of unexpected death CTA was a valuable addition to autopsy.
Rutty et al. performed total-body CTA in 210 cases of natural and non-suspicious unnatural death and found that CTA established a cause of death in 92% of cases. The number of discrepancies with the final cause of death was not significantly different between autopsy and CTA, suggesting that total-body CTA is a feasible alternative to autopsy. 26, 27 A drawback of CTA is that it requires specific training, technical equipment, and contrast agents and is time-consuming due to extensive preparation of the body (e.g. intra-arterial and/or intravenous femoral access for catheter placement) prior to scanning. At the time of the study, the equipment was not available and professional expertise and scanner availability to perform CTA was lacking.
Another non-invasive approach is the use of stand-alone MRI. Diffusion tensor imaging (DTI) is showing promising results in diagnosing myocardial ischaemia in situ, correctly predicting MI (either acute or chronic) with an accuracy of 0.73, using fractional anisotropy and mean diffusivity. 28 First studies show that quantitative MRI can detect and differentiate between early and following stages of myocardial ischaemia based on T1, T2, and proton density values. [29] [30] [31] They concluded that temperature-corrected quantitative MRI can diagnose early acute, acute and chronic MI, but histological confirmation is required. In the hospital setting, an important part of every postmortem examination should be a thorough evaluation of the medical history and clinical circumstances prior to death. The patients with known obstructive Today the use of postmortem imaging, mostly CT, is widely accepted as adjunct to the medicolegal autopsy. 7, 26, 27, 32, 33 In the hospital setting, there is a growing interest in postmortem imaging, however, expertise and logistics (e.g. access to scanners) are still important limitations.
Conclusion
We evaluated the diagnostic accuracy of MIA for the detection of ischaemic heart disease in a hospital setting. We found that the combination of MRI with biopsies had high sensitivity and specificity for the detection of acute and chronic MI.
